Clinical utility and patient adherence with ebastine for allergic rhinitis
Giorgio CiprandiDepartment of Internal Medicine, San Martino Hospital, Genoa, ItalyAbstract: Allergic rhinitis (AR) is a high prevalence disease, affecting 10%–20% of the general population. AR is sustained by an IgE-mediated reaction, and by a complex inflammatory network of cells, me...
Main Author: | Giorgio Ciprandi |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-10-01
|
Series: | Patient Preference and Adherence |
Online Access: | http://www.dovepress.com/clinical-utility-and-patient-adherence-with-ebastine-for-allergic-rhin-a5507 |
Similar Items
-
Ebastine in the treatment of patients with allergic rhinitis
by: A. Yu. Ovchinnikov, et al.
Published: (2019-08-01) -
Efficacy of ebastine in the treatment of allergic rhinitis
by: Mei Li
Published: (2016-05-01) -
Symptom Severity and Allergen-specific IgE in Allergic Rhinitis
by: Giorgio Ciprandi
Published: (2017-02-01) -
Bronchial hyperreactivity and spirometric impairment in polysensitized patients with allergic rhinitis
by: Tosca Maria A, et al.
Published: (2004-03-01) -
Tonsil Volume and Allergic Rhinitis in Children
by: Franco Ameli M.D., et al.
Published: (2014-09-01)